FDA 483 Database
FDA Form 483s Issued in March 2024
Every published Form FDA 483 issued in March 2024, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
7
Published 483s in March 2024
7
Distinct firms
Form 483s issued in March 2024
IntegraDose Compounding ServicesFDA
- FEI
- 3014483112
- Issued
- Mar 1, 2024
- Establishment
- Outsourcing Facility
- Location
- Minnesota, United States
Novo NordiskFDA
- FEI
- 3002807751
- Issued
- Mar 25, 2024
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- Denmark
Qualgen LLCFDA
- FEI
- 3011286349
- Issued
- Mar 19, 2024
- Establishment
- Outsourcing Facility
- Location
- Oklahoma, United States
Second Tokushima Factory, Otsuka Pharmaceutical Co. Ltd.FDA
- FEI
- 3002807834
- Issued
- Mar 22, 2024
- Establishment
- Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
- Location
- Japan
Jubilant DraxImage Radiopharmacies Inc.FDA
- FEI
- 3009339218
- Issued
- Mar 13, 2024
- Establishment
- Nuclear Pharmacy
- Location
- Florida, United States
Zydus Lifesciences LimitedFDA
- FEI
- 3007621329
- Issued
- Mar 27, 2024
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- India
Alkem Laboratories LimitedFDA
- FEI
- 3006370533
- Issued
- Mar 27, 2024
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- India
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| IntegraDose Compounding Services | 3014483112 | Outsourcing Facility | Minnesota, United States | Mar 1, 2024 | FDA |
| Novo Nordisk | 3002807751 | Active Pharmaceutical Ingredient Manufacturer | Denmark | Mar 25, 2024 | FDA |
| Qualgen LLC | 3011286349 | Outsourcing Facility | Oklahoma, United States | Mar 19, 2024 | FDA |
| Second Tokushima Factory, Otsuka Pharmaceutical Co. Ltd. | 3002807834 | Active Pharmaceutical Ingredient & Finished Dosage Manufacturer | Japan | Mar 22, 2024 | FDA |
| Jubilant DraxImage Radiopharmacies Inc. | 3009339218 | Nuclear Pharmacy | Florida, United States | Mar 13, 2024 | FDA |
| Zydus Lifesciences Limited | 3007621329 | Finished Pharmaceutical Manufacturer | India | Mar 27, 2024 | FDA |
| Alkem Laboratories Limited | 3006370533 | Finished Pharmaceutical Manufacturer | India | Mar 27, 2024 | FDA |